HBAN vs MGNX · P/E 13, rev $1.56B vs rev $39.6M
Huntington Bancshares Incorporated (HBAN) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the HBAN and MGNX stock pages for the full models.
Not investment advice.